Bo Hu
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 0.5%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (15 papers)Cancer-related molecular mechanisms research (14 papers)MicroRNA in disease regulation (12 papers)
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Bo Hu
111 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Molecular Biology 2.9k
- Oncology 2.5k
- Cancer Research 1.7k
- Immunology 1.5k
- Pulmonary and Respiratory Medicine 877
Countries citing papers authored by Bo Hu
This map shows the geographic impact of Bo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hu more than expected).
Fields of papers citing papers by Bo Hu
This network shows the impact of papers produced by Bo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hu. The network helps show where Bo Hu may publish in the future.
Co-authorship network of co-authors of Bo Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hu. A scholar is included among the top collaborators of Bo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hu. Bo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 26 | |
| 6 | 20 | |
| 7 | 15 | |
| 8 | 15 | |
| 9 | 87 | |
| 10 | 15 | |
| 11 | 13 | |
| 12 | 38 | |
| 13 | 98 | |
| 14 | 34 | |
| 15 | 123 | |
| 16 | 14 | |
| 17 | 98 | |
| 18 | Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinomabreakdown → | 1558 |
| 19 | 383 | |
| 20 | [Effect of lysis of acupotomology on plasma vasoactive substance levels in rats with third lumbar vertebra transverse process syndrome]. | 1 |
About Bo Hu
Bo Hu is a scholar working on Cancer Research, Hepatology and Oncology, having authored 118 papers that have together received 6.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer-related molecular mechanisms research (14 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.5k citations) and Hepatology (680 citations). Bo Hu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jia Fan, Xin‐Rong Yang, Yun‐Fan Sun, Jian Zhou, Yang Xu, Wei Guo, Shuang–Jian Qiu, Richard A. Flavell, Xin Zhang and Chao Sun. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.